Comerica Bank’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$129K Sell
11,507
-1,979
-15% -$22.6K ﹤0.01% 2522
2025
Q3
$156K Sell
13,486
-8,395
-38% -$98.3K ﹤0.01% 2438
2025
Q2
$268K Sell
21,881
-576
-3% -$7.24K ﹤0.01% 2189
2025
Q1
$322K Sell
22,457
-446
-2% -$6.96K ﹤0.01% 2086
2024
Q4
$365K Buy
22,903
+755
+3% +$14.9K ﹤0.01% 2042
2024
Q3
$532K Sell
22,148
-664
-3% -$15.2K ﹤0.01% 1858
2024
Q2
$454K Sell
22,812
-2,217
-9% -$43.2K ﹤0.01% 1880
2024
Q1
$498K Sell
25,029
-2,323
-8% -$44.9K ﹤0.01% 1873
2023
Q4
$613K Sell
27,352
-897
-3% -$18.5K ﹤0.01% 1775
2023
Q3
$571K Buy
+28,249
New +$640K ﹤0.01% 1728
2022
Q4
$792K Sell
27,475
-9,067
-25% -$222K 0.01% 1580
2022
Q3
$753K Sell
36,542
-4,807
-12% -$126K 0.01% 1619
2022
Q2
$1.13M Sell
41,349
-1,615
-4% -$46.4K 0.01% 1454
2022
Q1
$1.4M Buy
42,964
+2,217
+5% +$71.4K 0.01% 1384
2021
Q4
$1.3M Sell
40,747
-3,089
-7% -$99.9K 0.01% 1428
2021
Q3
$1.42M Sell
43,836
-1,644
-4% -$55.8K 0.01% 1521
2021
Q2
$1.48M Buy
45,480
+18,575
+69% +$768K 0.01% 1499
2021
Q1
$1.21M Sell
26,905
-1,389
-5% -$65.2K 0.01% 1662
2020
Q4
$1.35M Sell
28,294
-638
-2% -$26.6K 0.01% 1538
2020
Q3
$1.1M Sell
28,932
-328
-1% -$10.5K 0.01% 1500
2020
Q2
$933K Buy
29,260
+945
+3% +$27.4K 0.01% 1562
2020
Q1
$849K Buy
28,315
+44
+0.2% +$1.31K 0.01% 1449
2019
Q4
$798K Sell
28,271
-79
-0.3% -$2.86K 0.01% 1674
2019
Q3
$1.19M Buy
28,350
+698
+3% +$26.6K 0.01% 1421
2019
Q2
$1.11M Sell
27,652
-3,032
-10% -$130K 0.01% 1467
2019
Q1
$1.37M Sell
30,684
-163
-0.5% -$7.3K 0.01% 1377
2018
Q4
$1.37M Buy
30,847
+554
+2% +$29K 0.01% 1358
2018
Q3
$1.78M Sell
30,293
-5,646
-16% -$363K 0.01% 1226
2018
Q2
$2.08M Sell
35,939
-1,033
-3% -$54.6K 0.01% 1236
2018
Q1
$1.77M Sell
36,972
-12
-0% -$570 0.01% 1299
2017
Q4
$1.76M Buy
36,984
+163
+0.4% +$7.49K 0.01% 1351
2017
Q3
$1.57M Sell
36,821
-275
-0.7% -$11.7K 0.01% 1372
2017
Q2
$1.47M Sell
37,096
-62
-0.2% -$2.34K 0.01% 1372
2017
Q1
$1.46M Buy
37,158
+1,535
+4% +$59.8K 0.01% 1414
2016
Q4
$1.39M Buy
35,623
+1,815
+5% +$64.9K 0.01% 1425
2016
Q3
$1.16M Sell
33,808
-2,942
-8% -$103K 0.01% 1427
2016
Q2
$1.34M Buy
36,750
+336
+0.9% +$10.3K 0.01% 1338
2016
Q1
$1.13M Sell
36,414
-3,539
-9% -$94.3K 0.01% 1403
2015
Q4
$1.16M Sell
39,953
-2,292
-5% -$71.3K 0.01% 1319
2015
Q3
$1.2M Sell
42,245
-40,783
-49% -$1.42M 0.01% 1333
2015
Q2
$3.36M Buy
83,028
+32,378
+64% +$1.45M 0.01% 1196
2015
Q1
$2.49M Buy
+50,650
New +$2.35M 0.02% 943

Other funds holding AVNS

Comerica Bank's AVNS Position: Q4 2025 in Review

Comerica Bank reduced its Avanos Medical (AVNS) stake by 15% in Q4 2025, selling an estimated $22.6K and leaving 11,507 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #2522.

Comerica Bank first reported a position in AVNS in Q1 2015 and has held it in 42 quarters since. The position peaked at $3.36M in Q2 2015. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Comerica Bank held 11,507 shares of Avanos Medical worth $129K as of Q4 2025.
  • Comerica Bank sold 1,979 Avanos Medical shares in Q4 2025, an estimated $22.6K.
  • Avanos Medical made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2522 holding.
  • Comerica Bank first reported a position in Avanos Medical in Q1 2015 and has held it in 42 quarters since.
  • Comerica Bank's Avanos Medical position peaked at $3.36M in Q2 2015.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.